Mason & Associates (California)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,097	Closed	-$309K	–	87
2022 Q2	$309K	Hold	1,097	–	–	0.11%	67
2022 Q1	$286K	Hold	1,097	–	–	0.09%	91
2021 Q4	$241K	Buy	+1,097	New	+$241K	0.07%	89